PT-141

Melanocortin Receptor Signaling & Neuroendocrine Research Pathways

Each vial contains 10mg of high-purity PT-141, a synthetic peptide studied in laboratory research for its interaction with biological pathways associated with melanocortin receptor signaling and neuroendocrine regulatory mechanisms.

PT-141, also known as Bremelanotide, is a synthetic cyclic peptide analogue derived from melanocortin peptides. In scientific research environments, peptides within this class are studied for their interaction with biological systems associated with melanocortin receptor pathways, peptide-mediated neural communication, and neuroendocrine regulatory signaling mechanisms.

Researchers investigate PT-141 in laboratory environments to better understand its interaction with molecular pathways involved in melanocortin receptor signaling, neuroendocrine communication systems, and peptide-mediated hormonal regulatory mechanisms. Experimental studies also explore how melanocortin analogue peptides interact with biological systems related to neurochemical signaling pathways and central regulatory communication mechanisms.

Because of these characteristics, peptides such as PT-141 are studied in experimental research focused on melanocortin receptor biology, neuroendocrine signaling pathways, and peptide-mediated neural communication mechanisms.

All products are manufactured using high-purity peptide synthesis and controlled lyophilization processes to maintain stability and structural integrity for laboratory and scientific research applications.

Important Notice

This product is intended for laboratory research and scientific purposes only.

It is not approved by Health Canada, the FDA, or any other regulatory authority for human or veterinary use.
This product is not intended to diagnose, treat, cure, or prevent any disease.

By purchasing this product, customers acknowledge that it is strictly for research use only.